TrialJournal of the American Heart Association2016

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study.

Erik Stroes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.